A phase II study of lenalidomide (CC-5013) in combination with prednisone for the treatment of myelofibrosis with myeloid metaplasia
Phase of Trial: Phase II
Latest Information Update: 25 Sep 2013
At a glance
- Drugs Lenalidomide (Primary) ; Prednisone
- Indications Myelofibrosis
- Focus Therapeutic Use
- 22 Jul 2010 Results have been published online in Blood.
- 20 Sep 2007 Status changed from recruiting to in progress.
- 18 Jan 2007 Status changed from suspended to recruiting.